BR112017023886A2 - forma cristalina inovadora de picoxistrobina, método para preparação e uso da mesma - Google Patents

forma cristalina inovadora de picoxistrobina, método para preparação e uso da mesma

Info

Publication number
BR112017023886A2
BR112017023886A2 BR112017023886A BR112017023886A BR112017023886A2 BR 112017023886 A2 BR112017023886 A2 BR 112017023886A2 BR 112017023886 A BR112017023886 A BR 112017023886A BR 112017023886 A BR112017023886 A BR 112017023886A BR 112017023886 A2 BR112017023886 A2 BR 112017023886A2
Authority
BR
Brazil
Prior art keywords
crystalline form
picoxystrobin
innovative crystalline
preparing
innovative
Prior art date
Application number
BR112017023886A
Other languages
English (en)
Portuguese (pt)
Inventor
Timothy Bristow James
Original Assignee
Jiangsu Rotam Chemistry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Rotam Chemistry Co Ltd filed Critical Jiangsu Rotam Chemistry Co Ltd
Publication of BR112017023886A2 publication Critical patent/BR112017023886A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112017023886A 2016-01-19 2017-01-18 forma cristalina inovadora de picoxistrobina, método para preparação e uso da mesma BR112017023886A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1600977.1A GB2546498B (en) 2016-01-19 2016-01-19 Novel crystalline form of picoxystrobin, method of preparing and use of the same
PCT/CN2017/071499 WO2017125010A1 (en) 2016-01-19 2017-01-18 Novel crystalline form of picoxystrobin, method of preparing and use of the same

Publications (1)

Publication Number Publication Date
BR112017023886A2 true BR112017023886A2 (pt) 2018-07-17

Family

ID=55488178

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017023886A BR112017023886A2 (pt) 2016-01-19 2017-01-18 forma cristalina inovadora de picoxistrobina, método para preparação e uso da mesma

Country Status (7)

Country Link
CN (1) CN108368047B (es)
AR (1) AR107167A1 (es)
BR (1) BR112017023886A2 (es)
GB (1) GB2546498B (es)
MX (1) MX2018007273A (es)
TW (1) TWI721083B (es)
WO (1) WO2017125010A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022072650A1 (en) 2020-10-01 2022-04-07 Corteva Agriscience Llc Polymorphs of compounds having pesticidal activity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69615844T2 (de) * 1995-06-28 2002-05-16 Syngenta Ltd Verfahren zur herstellung von 2-(6-substituiertes pyrid-2-yloxy methyl) phenylacetat
CN102115458B (zh) * 2010-11-25 2019-12-13 大连九信精细化工有限公司 3-甲氧基-2-芳香基丙烯酸甲酯类化合物的合成方法
CN103030598B (zh) * 2012-12-17 2016-04-13 上海禾本药业股份有限公司 甲氧基丙烯酸酯类杀菌剂的制备方法
CN103626691B (zh) * 2013-11-11 2015-10-21 上海禾本药业有限公司 啶氧菌酯的制备方法
CN104262239B (zh) * 2014-08-25 2016-08-17 浙江泰达作物科技有限公司 一种绿色高效农用杀菌剂的合成工艺
CN104230794A (zh) * 2014-08-25 2014-12-24 浙江泰达作物科技有限公司 一种高效绿色农用杀菌剂的合成方法
CN104151233A (zh) * 2014-08-25 2014-11-19 浙江泰达作物科技有限公司 一种农用杀菌剂的制备方法

Also Published As

Publication number Publication date
AR107167A1 (es) 2018-03-28
GB201600977D0 (en) 2016-03-02
GB2546498A (en) 2017-07-26
WO2017125010A1 (en) 2017-07-27
TWI721083B (zh) 2021-03-11
CN108368047B (zh) 2022-06-10
GB2546498B (en) 2020-04-08
TW201731818A (zh) 2017-09-16
CN108368047A (zh) 2018-08-03
MX2018007273A (es) 2018-11-09

Similar Documents

Publication Publication Date Title
NI201700095A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
CL2018000730A1 (es) Compuestos heterocíclicos y usos de los mismos
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
CO2018013105A2 (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
UY38070A (es) Derivados de quinazolina y piridopirimidina sustituidos útiles como agentes anticáncer
DK3577110T3 (da) 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl-substituerede forbindelser som hiv-inhibitorer
CO2018002063A2 (es) Análogos novedosos de nucleósidos sustituidos en el anillo aromático bicíclico 6-6 para su uso como inhibidores de prmt5
CL2017001923A1 (es) Derivados de 9h-pirrolo-dipiridina
BR112016000489A8 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
CR20160099A (es) Formulación de inhibidores de la syk
DOP2018000082A (es) NUEVOS DERIVADOS DE PIRROLO[2,3-d]PIRIMIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
EA202091505A1 (ru) Триазолазолы циклогексильной кислоты в качестве антагонистов lpa
BR112015022804A2 (pt) novos derivados de octahidro-pirrol [3,4-c]-pirrol e seus análogos como inibidores de autotaxina
EA201791304A1 (ru) Производные изохинолина для лечения вич
UY35300A (es) Formulación de combinación de dos compuestos antivirales
EA201500875A1 (ru) СОЛИ ПРОИЗВОДНЫХ 2-АМИНО-1-ГИДРОКСИЭТИЛ-8-ГИДРОКСИХИНОЛИН-2-(1Н)-ОНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3
BR112019025028A2 (pt) Método para preparar um composto.
CL2018001067A1 (es) Compuesto piranodipiridínico.
CR20180181A (es) Nuevos derivados de imidazol[4,5-b]piridina, un proceso para su preparación y composiciones farmacéuticas que los contienen
CO2019011547A2 (es) Compuesto sólido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol
CY1122423T1 (el) Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1
BR112017018580A2 (pt) p-toluenossulfonato para inibidor de mek quinase, e forma cristalina do mesmo e método de preparação para tal
BR112017023886A2 (pt) forma cristalina inovadora de picoxistrobina, método para preparação e uso da mesma
AR102569A1 (es) Síntesis de inhibidor de pi3k, formas cristalinas y sales del mismo y una composición farmacéutica que lo comprende
ECSP17063489A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]